Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myeloid, Chronic-Phase × entrectinib × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 6 Brain Neoplasms 3 Thyroid Cancer, Papillary 2 Sarcoma 2 Salivary Gland Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Glioma 2 Central Nervous System Neoplasms 2 Wilms Tumor 1 Solid Tumors 1 Sarcoma, Ewing 1 Recurrence 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Neuroblastoma 1 Nephroma, Mesoblastic 1 Neoplasms, Unknown Primary 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Melanoma 1 Medulloblastoma 1 Lymphoproliferative Disorders 1 Lymphoma, Large-Cell, Anaplastic 1 Leukemia, Myeloid, Acute 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1

Interventions

nilotinib 6 asciminib 6 Dasatinib 6 Imatinib Mesylate 5 bosutinib 4 Cyclophosphamide 4 fludarabine phosphate 3 Whole-Body Irradiation 3 ruxolitinib 2 ponatinib 2 letermovir 2 Tacrolimus 2 Peripheral Blood Stem Cell Transplantation 2 Mycophenolic Acid 2 Methotrexate 2 Melphalan 2 Cyclosporine 2 Busulfan 2 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 olverembatinib 1 decitabine and cedazuridine drug combination 1 Vorinostat 1 Valganciclovir 1 Therapeutics 1 Stem Cell Transplantation 1 Specimen Handling 1 Sirolimus 1 Rituximab 1 Practice Management, Medical 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡